Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
Massachusetts Governor Maura Healey Named BIO’s…
Annual award honors governors for their leadership and commitment to strengthening biotechnology in their state BOSTON (June 17, 2025) – Today, the Biotechnology Innovation Organization (BIO) named Massachusetts Governor Maura Healey…
Learn more
BIO Elects Genentech’s Fritz Bittenbender as New…
Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…
Learn more
BIO International Convention Opens in Boston,…
The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanityBOSTON (June 16, 2025) The BIO International Convention, the world’s largest and most comprehensive event for…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
FDA Commissioner, Dr. Scott Gottlieb, to Address BIO Patient and Health Advocacy Summit
September 5, 2017
The head of the United States Food and Drug Administration, Dr. Scott Gottlieb, will be the keynote speaker at the BIO Patient and Health Advocacy Summit, October 2-3 at the Mayflower Hotel in Washington, DC. The annual event brings together…
PhRMA and BIO Initiate Litigation to Challenge Unconstitutional Provisions of Nevada’s SB 539
September 1, 2017
Washington, DC (September 1, 2017) – The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) today initiated litigation in the United States District Court for the District of Nevada…
BIO Asks EPA To Use a Forward-Looking Methodology in Setting Renewable Fuel Standards
August 31, 2017
BIO today submitted comments on EPA's proposed rule on the Renewable Fuel Standard Program: Standards for 2018 and Biomass-Based Diesel Volume for 2019.
BIO Statement on Nomination of Andrei Iancu to Lead U.S. Patent and Trademark Office
August 29, 2017
Washington, D.C. (August 29, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement on the nomination of Andrei Iancu to lead the U.S. Patent and Trademark Office:“BIO congratulates Mr…
BIO Applauds Signing of Food and Drug Administration Reauthorization Act (FDARA)
August 18, 2017
Enactment of FDA User Fee package important victory for patients, medical innovation
Fireside Chat Speakers, Programming Announced for 2017 BIO Investor Forum
August 15, 2017
BIO announces programming for the upcoming BIO Investor Conference Oct. 17-18 in San Francisco including Kristina Burow, Managing Director of ARCH Venture Partners and Dr. Richard Scheller, Chief Science Officer & Head of Therapeutics…
BIO: Senate Passage of FDA User Fee Package Important Victory for Patients, Medical Innovation
August 3, 2017
Washington, DC (August 3, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement regarding passage of the Food and Drug Administration Reauthorization Act (FDARA) by the U.S…
BIO Applauds US Court of Appeals Decision on the Renewable Fuel Standard
July 28, 2017
The U.S. Court of Appeals for the District of Columbia Circuit today supported BIO's argument that the RFS statute does not allow EPA to rely on demand-side factors under the oil industry’s control as a basis for setting annual renewable fuel…
The 2017 BIO World Congress Comes to a Close in Montreal
July 26, 2017
The 14th annual BIO World Congress drew 954 attendees. The world’s largest industrial biotechnology event hosted more than 227 speakers in seven education tracks and five plenaries and set a new conference record for partnering meetings.
Democrats' Plan on Drug Costs a “Bad Deal for Patients and the Future of American Innovation”
July 24, 2017
Plan will restrict seniors’ access to prescription drugs and undermine quest for biopharmaceutical innovations and curesWashington, DC (July 24, 2017) – Biotechnology Innovation Organization (BIO) Director of Communications Brian Newell…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today